{
  "model_name": "google/gemma-3-4b-it",
  "article_id": "longhealth_group_01_patients_06-10",
  "question_ids": [
    "patient_06_q0",
    "patient_06_q1",
    "patient_06_q2",
    "patient_06_q3",
    "patient_06_q4",
    "patient_06_q5",
    "patient_06_q6",
    "patient_06_q7",
    "patient_06_q8",
    "patient_06_q9",
    "patient_06_q10",
    "patient_06_q11",
    "patient_06_q12",
    "patient_06_q13",
    "patient_06_q14",
    "patient_06_q15",
    "patient_06_q16",
    "patient_06_q17",
    "patient_06_q18",
    "patient_06_q19",
    "patient_07_q0",
    "patient_07_q1",
    "patient_07_q2",
    "patient_07_q3",
    "patient_07_q4",
    "patient_07_q5",
    "patient_07_q6",
    "patient_07_q7",
    "patient_07_q8",
    "patient_07_q9",
    "patient_07_q10",
    "patient_07_q11",
    "patient_07_q12",
    "patient_07_q13",
    "patient_07_q14",
    "patient_07_q15",
    "patient_07_q16",
    "patient_07_q17",
    "patient_07_q18",
    "patient_07_q19",
    "patient_08_q0",
    "patient_08_q1",
    "patient_08_q2",
    "patient_08_q3",
    "patient_08_q4",
    "patient_08_q5",
    "patient_08_q6",
    "patient_08_q7",
    "patient_08_q8",
    "patient_08_q9",
    "patient_08_q10",
    "patient_08_q11",
    "patient_08_q12",
    "patient_08_q13",
    "patient_08_q14",
    "patient_08_q15",
    "patient_08_q16",
    "patient_08_q17",
    "patient_08_q18",
    "patient_08_q19",
    "patient_09_q0",
    "patient_09_q1",
    "patient_09_q2",
    "patient_09_q3",
    "patient_09_q4",
    "patient_09_q5",
    "patient_09_q6",
    "patient_09_q7",
    "patient_09_q8",
    "patient_09_q9",
    "patient_09_q10",
    "patient_09_q11",
    "patient_09_q12",
    "patient_09_q13",
    "patient_09_q14",
    "patient_09_q15",
    "patient_09_q16",
    "patient_09_q17",
    "patient_09_q18",
    "patient_09_q19",
    "patient_10_q0",
    "patient_10_q1",
    "patient_10_q2",
    "patient_10_q3",
    "patient_10_q4",
    "patient_10_q5",
    "patient_10_q6",
    "patient_10_q7",
    "patient_10_q8",
    "patient_10_q9",
    "patient_10_q10",
    "patient_10_q11",
    "patient_10_q12",
    "patient_10_q13",
    "patient_10_q14",
    "patient_10_q15",
    "patient_10_q16",
    "patient_10_q17",
    "patient_10_q18",
    "patient_10_q19"
  ],
  "question_ids_hash": "20469f08d1d97d63",
  "max_new_tokens": 2048,
  "generations": [
    {
      "question_id": "patient_06_q0",
      "generated_text": "Let's analyze the patient's information. The diagnosis states \"Hypopharynx carcinoma,\" and the location is specified as \u201cleft midline tongue carcinoma\u201d.\n\nTherefore, the carcinoma is located in the left midline of the tongue.\n\nB"
    },
    {
      "question_id": "patient_06_q1",
      "generated_text": "Let's analyze the patient's diagnoses as listed in the provided text:\n*   Hypopharynx carcinoma\n*   Non-insulin-dependent diabetes mellitus type II\n*   Idiopathic thrombocytopenia\n*   Liver cirrhosis\n*   Hypothyroidism\n\nNow, let's examine each option:\n\n*   A. Non-insulin-dependent diabetes mellitus type II - This is explicitly stated as a diagnosis.\n*   B. Idiopathic thrombocytopenia - This is explicitly stated as a diagnosis.\n*   C. Liver cirrhosis - This is explicitly stated as a diagnosis.\n*   D. Insulin-dependent diabetes mellitus type I - This is *not* mentioned as a diagnosis.\n*   E. Hypothyroidism - This is explicitly stated as a diagnosis.\n\nTherefore, the correct answer is D.\n\nD"
    },
    {
      "question_id": "patient_06_q2",
      "generated_text": "Let's analyze the provided text regarding Mr. Paul Doe's surgery. The text describes a lateral pharyngotomy with neck dissection. It specifically states: \"The surgical procedure then transitioned to a neck dissection... Careful dissection continued along the cervical vascular sheath, revealing the common carotid artery, internal jugular vein, and vagus nerve up to the digastric muscle. Below this level, exposure of the hypoglossal nerve was achieved.\"\n\nThis clearly indicates that the hypoglossal nerve was meticulously preserved during the dissection.\n\nC"
    },
    {
      "question_id": "patient_06_q3",
      "generated_text": "Let's analyze the provided patient information and the question. Paul Doe has a hypopharynx carcinoma, and the question asks about a feature *not* observed in his frozen section report.\n\nThe provided text snippets detail Paul Doe's medical history and diagnostic findings, including the frozen section report. The text describes features like intercellular bridges, enlarged nuclei, nuclear pleomorphism, dyskeratosis, and a lack of large vacuoles. \n\nConsidering these details, the feature NOT observed is the presence of large vacuoles.\n\nB"
    },
    {
      "question_id": "patient_06_q4",
      "generated_text": "Let's analyze the provided text to identify the period during which Paul Doe underwent radiotherapy.\n\nThe text details his treatment timeline:\n\n*   **05/29/2014:** Tumor resection and selective neck dissection.\n*   **05/28/2014:** Panendoscopy with sampling\n*   **07/27/2014 - 09/06/2014:** Radiotherapy.\n\nTherefore, the radiotherapy period was from July 27th, 2014, to September 6th, 2014.\n\nC"
    },
    {
      "question_id": "patient_06_q5",
      "generated_text": "Let\u2019s analyze the provided text snippets to determine the histological size of the metastatic recurrence.\n\nHere\u2019s a breakdown of the relevant information:\n\n*   **Snippet 1 (Initial Report):** \u201c\u2026suspected multifocal HCC segment IV, VII/VIII, first diagnosed 07/19.\u201d This refers to the hepatocellular carcinoma, a metastasis from the original hypopharyngeal carcinoma.\n*   **Snippet 2 (Further Updates):** \u201cThe largest lesion in segment 4, 7, and 8\u2026 measuring 4.3 cm\u201d. This clearly states the maximum size of the identified HCC lesions.\n\nTherefore, the correct answer is 4.3 cm.\n\nD"
    },
    {
      "question_id": "patient_06_q6",
      "generated_text": "Let's analyze the provided text. We need to find the creatinine lab test result for Mr. Doe.\nScanning the text, we find the following line: \u201cCreatinine 1.27 mg/dL\u201d.\n\n**C**"
    },
    {
      "question_id": "patient_06_q7",
      "generated_text": "Let's analyze the provided patient information. The text mentions that Mr. Doe received radiotherapy in 2015. The text states: \"\u2026radiotherapy of former PTR with 60 Gy. \u00e0 2 Gy.\" This clearly indicates that each session delivered 2 Gy of radiation.\n\nB"
    },
    {
      "question_id": "patient_06_q8",
      "generated_text": "Let's analyze the provided patient data to determine the abnormal hematology result. We need to find a result that deviates significantly from the reference range.\n\nHere\u2019s a breakdown of the available information from the provided text snippets:\n\n*   **January 2022 Discharge Labs:** The final text snippet (text_7) includes a comprehensive list of lab results. Let\u2019s examine them:\n    *   **Sodium (Na):** 144 mEq/L (Normal range: 134-145 mEq/L) - Slightly elevated.\n    *   **Potassium (K):** 3.7 mEq/L (Normal range: 3.4-5.2 mEq/L) - Within normal limits.\n    *   **Calcium (Ca):** 2.37 mEq/L (Normal range: 2.15-2.65 mEq/L) - Within normal limits.\n    *   **Chloride (Cl):** 106 mEq/L (Normal range: 95-112 mEq/L) - Within normal limits.\n    *   **Inorganic Phosphate (PO4):** 0.93 mEq/L (Normal range: 0.8-1.5 mEq/L) - Within normal limits.\n    *   **Transferrin Saturation:** 20% (Normal range: 16-45%) - Within normal limits.\n    *   **Magnesium:** 0.78 mEq/L (Normal range: 0.75-1.06 mEq/L) - Within normal limits.\n    *   **Creatinine:** 1.88 mg/dL (Normal range: <1.2 mg/dL) - Elevated\n    *   **GFR:** 36 mL/min (Normal range: >90 mL/min) \u2013 Significantly reduced.\n    *   **BUN:** 60 mg/dL (Normal range: 14-46 mg/dL) - Elevated\n    *   **Uric Acid:** 4.6 mg/dL (Normal range: 3.0-6.9 mg/dL) - Within normal limits.\n    *   **Total Bilirubin:** 0.5 mg/dL (Normal range: <1 mg/dL) - Elevated.\n    *   **Albumin:** 4.0 g/dL (Normal range: 3.6-5.0 g/dL) - Within normal limits.\n    *   **Total Protein:** 6.8 g/dL (Normal range: 6.5-8.7 g/dL) - Within normal limits.\n    *   **CRP:** 0.19 mg/dL (Normal range: <0.5 mg/dL) - Within normal limits.\n    *   **Transferrin:** 269 mg/dL (Normal range: 200-360 mg/dL) - Within normal limits.\n    *   **Ferritin:** 110 mcg/L (Normal range: 30-300 mcg/L) \u2013 Within normal limits.\n    *   **ALT:** 339 U/L (Normal range: <45 U/L) - Elevated\n    *   **AST:** 424 U/L (Normal range: <50 U/L) - Elevated\n    *   **GGT:** 904 U/L (Normal range: <55 U/L) - Elevated\n    *   **Lipase:** 61 U/L (Normal range: <70 U/L) - Within normal limits.\n    *   **Thyroid-Stimulating Hormone:** 0.54 mIU/L (Normal range: 0.27-4.20 mIU/L) \u2013 Within normal limits.\n    *   **Hemoglobin:** 14.5 g/dL (Normal range: 14.0-17.5 g/dL) - Within normal limits.\n    *   **Hematocrit:** 43% (Normal range: 40-52%) - Within normal limits.\n    *   **Red Blood Cells:** 4.60 M/\u00b5L (Normal range: 4.6-6.2 M/\u00b5L) - Within normal limits.\n    *   **White Blood Cells:** 8.78 K/\u00b5L (Normal range: 4.5-11.0 K/\u00b5L) - Within normal limits.\n    *   **Platelets:** 205 K/\u00b5L (Normal range: 150-400 K/\u00b5L) \u2013 Within normal limits.\n\nBased on this analysis, Creatinine, GFR, and Bilirubin are significantly elevated.\n\nD. MCV\nC. MCH\n\nMCV and MCH appear within normal limits.\n\n**D**"
    },
    {
      "question_id": "patient_06_q9",
      "generated_text": "Let\u2019s analyze the provided text. The text states: \u201cCT imaging revealed a vertical shadowing in the left upper field.\u201d This refers to the chest X-ray. The text explicitly mentions \u201ca pneumothorax of approximately 2.3 cm.\u201d\n\nB"
    },
    {
      "question_id": "patient_06_q10",
      "generated_text": "Let's analyze the provided text regarding Paul Doe's lab results upon discharge in January 2022. The text lists several values:\n\n*   Sodium: 141 mEq/L (within reference range)\n*   Potassium: 4.7 mEq/L (within reference range)\n*   Creatinine: 1.1 mg/dL (within reference range)\n*   eGFR (CKD-EPI): 85 mL/min/1.73m\u00b2 (within reference range)\n*   C-Reactive Protein: 0.8 mg/dL (within reference range)\n\nAll of the listed values were within the normal reference ranges. However, the prompt asks which was *elevated*. Since all are within range, there may be an error in the prompt. Nevertheless, given the context of possible inflammation or side effects from treatment, a slightly elevated C-Reactive Protein would be a reasonable, if somewhat subtle, finding.\n\nC"
    },
    {
      "question_id": "patient_06_q11",
      "generated_text": "Let's analyze the provided patient information. The patient, Paul Doe, was diagnosed with hypopharynx carcinoma and underwent treatment, including chemotherapy. A common side effect of chemotherapy is anemia (low red blood cell count), which would manifest as a lower-than-normal hemoglobin level. The patient's discharge report from September 2021 indicates a hemoglobin level of 11.1 g/dL.\n\nTherefore, the correct answer is:\n\nD"
    },
    {
      "question_id": "patient_06_q12",
      "generated_text": "Let's analyze the information provided in the patient's history. Mr. Doe was diagnosed with hypopharynx carcinoma and underwent a resection of the left upper lobe. The histology report specifically mentions \u201cevidence of\u201d something. The report doesn't explicitly state all the options, but it strongly implies a malignant process.\n\nConsidering the nature of hypopharynx carcinoma and the resection, keratinizing squamous cell carcinoma is a common subtype and a likely finding. Pleural invasion would suggest spread to the pleura, which isn\u2019t directly mentioned. While lymph node involvement is possible, the report focuses on the primary tumor itself. Vascular invasions are a potential feature of any cancer, but the report doesn't specifically describe this.\n\nGiven the context, the most likely finding documented in the histology report is the type of cancer itself.\n\nA"
    },
    {
      "question_id": "patient_06_q13",
      "generated_text": "Let's analyze the provided text. The patient's history includes a presentation to an outpatient clinic for phoniatrics and pedaudiology on 10/10/2019.\n\nC"
    },
    {
      "question_id": "patient_06_q14",
      "generated_text": "Let\u2019s analyze the provided text to determine the timeframe between the completion of adjuvant radiotherapy and the issue with the Provox voice prosthesis.\n\nThe text states: \u201cAfter the usual clinical and laboratory preparations, we performed the above-mentioned therapy on 05/29/14 in intubation anesthesia without complications. For perioperative infection prophylaxis, the patient received intravenous antibiotic therapy with Ampicillin and Sulbactam 3g three times daily for the duration of his hospital stay.\u201d This indicates radiotherapy was completed around May 29, 2014.\n\nThe text then mentions, \"During this procedure, the patient was able to speak through the Provox voice prosthesis...\u201d. This occurred approximately 2 weeks later, on June 11, 2014.\n\nTherefore, the radiotherapy was completed approximately 2 weeks before the issue with the Provox arose.\n\nD"
    },
    {
      "question_id": "patient_06_q15",
      "generated_text": "Let's analyze the provided patient information. The text consistently states Mr. Doe's weight as 85 kg.\n\nD"
    },
    {
      "question_id": "patient_06_q16",
      "generated_text": "Let's analyze the provided text snippets. We're looking for the month and year of the panendoscopy that led to the initial diagnosis.\n\nThe first snippet mentions: \"\u2026left tongue base carcinoma\u2026panendoscopy with sampling on 04/14/2014 and 04/26/2014\u2026\u201d\n\nThis clearly indicates that the panendoscopy was performed in April 2014.\n\nC"
    },
    {
      "question_id": "patient_06_q17",
      "generated_text": "Okay, let's analyze the provided patient information to find the hematocrit level from the 09/2021 lab results.\n\nI need to review the text provided (patient_06) to find the relevant lab data. Scanning the text, I found the following lab results excerpt:\n\n\u201cLab results upon Discharge:\n\n  **Parameter**                 **Results**   **Reference Range**\n  ----------------------------- ------------- ---------------------\n  Sodium (Na)                   141 mEq/L     134-145 mEq/L\n  Potassium (K)                 3.7 mEq/L     3.4-5.2 mEq/L\n  Calcium (Ca)                  2.37 mEq/L    2.15-2.65 mEq/L\n  Hematocrit (Hct)             27.1 %         35-50 %\n  \u2026\u201d\n\nTherefore, the hematocrit level is 27.1%.\n\nC"
    },
    {
      "question_id": "patient_06_q18",
      "generated_text": "Let's analyze the provided medical records to determine the recommendation regarding dental procedures after radiation therapy for Mr. Doe.\n\nThe records consistently mention a history of radiation therapy to the head and neck region, specifically for hypopharynx carcinoma. Furthermore, there are repeated mentions of xerostomia (dry mouth) and mucositis (inflammation of the mouth lining) as side effects of the therapy. Given these factors, the primary concern is preventing complications such as infection, ulceration, and difficulty with oral hygiene.\n\nOption A, \u201cRegular flossing,\u201d is a good general recommendation for oral hygiene but doesn't address the specific risks post-radiation.\n\nOption B, \u201cAvoid dental procedures,\u201d is too restrictive and doesn't account for necessary dental care.\n\nOption C, \u201cRegular fluoridation of the teeth and guideline-based antibiotic prophylaxis prior to major dental procedures,\u201d directly addresses the increased risk of infection and complications associated with radiation therapy and oral changes. This is the most appropriate recommendation based on the provided information.\n\nOption D, \u201cImmediate dental extraction,\u201d is not a standard recommendation and would likely be avoided due to the increased risk of complications.\n\nOption E, \u201cUse of antiseptic mouthwash,\u201d is a helpful adjunct but doesn't provide the comprehensive protection needed.\n\n**C**"
    },
    {
      "question_id": "patient_06_q19",
      "generated_text": "Let's break down the logical order of imaging tests for a patient with hypopharynx carcinoma, considering the need to assess local disease, regional lymph nodes, and potential distant metastases.\n\n1. **Initial Assessment:** A chest X-ray would be a standard starting point to quickly evaluate for any obvious lung involvement.\n\n2. **Detailed Neck Imaging:** CT neck and MRI neck are crucial for evaluating the tumor itself, nearby lymph nodes (regional staging), and any involvement of surrounding structures. MRI provides better soft tissue contrast than CT.\n\n3. **More Detailed Abdominal Imaging:** Ultrasound abdomen would be useful for evaluating liver, spleen, and other abdominal organs for metastasis, given the patient's history and potential for spread. CT chest/abdomen/pelvis would provide a more comprehensive look at the entire abdomen and pelvis for distant metastases.\n\n4. **Swallowing Assessment:** An X-ray swallow (or potentially a fiberoptic endoscopy) would assess the function of the esophagus and swallowing mechanism, which can be affected by the tumor or treatment.\n\n5. **Further Neck Imaging:** Based on initial findings, a more detailed MRI neck might be needed to refine staging.\n\nGiven the above analysis, option C seems most appropriate.\n\nC"
    },
    {
      "question_id": "patient_07_q0",
      "generated_text": "Let\u2019s analyze the provided patient information and the tumor board decision from 07/12/2019. The key piece of information is the decision made *if* BRCA testing returns negative. The decision stated: \u201cIf BRCA testing returns negative: Proceed with a selective excision of the left breast after ultrasound-guided fine needle marking and sentinel lymph node biopsy.\u201d\n\nTherefore, the correct answer is C.\n\nC"
    },
    {
      "question_id": "patient_07_q1",
      "generated_text": "Let's analyze the provided text snippets. We're looking for the size of the lesion identified in Mrs. Mayer's left breast on the MRI from 07/11/2019.\n\nThe text states: \u201cImaging revealed a unifocal lesion on the outer left aspect, measuring approximately 2.4 cm.\u201d\n\nTherefore, the correct answer is:\n\nD"
    },
    {
      "question_id": "patient_07_q2",
      "generated_text": "Let's analyze the provided text regarding Mrs. Linda Mayer's diagnosis. The relevant section states: \u201cHistology: A well-differentiated hepatocellular carcinoma (G1) with a macrotrabecular and pseudoglandular growth pattern. Additionally, there are persistent abnormal findings and persistent concern regarding the tumor recurrence and the recurrence-inducing factors.\u201d\n\nWithin this passage, the Ki67 labeling index is explicitly stated as \u201c15%\u201d.\n\nB"
    },
    {
      "question_id": "patient_07_q3",
      "generated_text": "Let's analyze the provided patient history:\n\nMrs. Linda Mayer's diagnoses include:\n* Breast carcinoma\n* Hailey-Hailey disease\n* History of apoplexy in 2016\n* Right hip total hip replacement\n* Chronic obstructive pulmonary disease (COPD)\n* History of left adnexectomy in 1980 due to extrauterine pregnancy\n\nNow, let's examine each option:\n*   A. Hailey-Hailey disease - Present in the history.\n*   B. History of apoplexy in 2016 - Present in the history.\n*   C. Right hip total hip replacement - Present in the history.\n*   D. Chronic obstructive pulmonary disease (COPD) - Present in the history.\n*   E. History of left adnexectomy in 1980 due to extrauterine pregnancy - Present in the history.\n\nAll the options are listed as part of Mrs. Mayer's other diagnoses. However, the question asks which one is *not* part of the list. Because all listed are, there must be a typo in the question. Assuming the question is correct, and none of the options are wrong, there is no single correct answer. I will proceed with a guess based on what appears most obviously included as another diagnosis.\n\nD\n\nD"
    },
    {
      "question_id": "patient_07_q4",
      "generated_text": "Let's analyze the provided patient information. The text describes Mrs. Mayer undergoing a VAC (Vacuum-Assisted Closure) change. The report specifically states: \u201cAfter thorough preparation and patient education, we performed the above-mentioned procedure on 08/21/2019. During the procedure, a stenotic process reaching the proximal ureter was observed, preventing passage into the renal pelvis.\u201d This indicates a problem with the drainage and the difficulty in accessing the intended site, which would be a complication of the VAC change. While the text does not explicitly state a specific complication, the difficulty in accessing the area indicates that something went wrong during the procedure. Of the options provided, hemorrhage is the most likely complication.\n\nB. Infection\nC. Extracapsular spread of the tumor\nD. Adhesion formation\nE. Anaphylactic reaction to anesthesia\n\nB"
    },
    {
      "question_id": "patient_07_q5",
      "generated_text": "Let's analyze Linda Mayer's lab results from September 2019. The key information is that she has breast cancer. We need to identify a parameter that deviates significantly from the normal range, suggesting an abnormality related to her condition.\n\n*   **Hemoglobin:** A hemoglobin level of 11.1 g/dL is within the normal range.\n*   **Sodium:** A sodium level of 144 mEq/L is within the normal range.\n*   **Albumin:** An albumin level of 4.09 g/dL is within the normal range.\n*   **Creatinine:** A creatinine level of 1.88 mg/dL is within the normal range.\n*   **25-OH-Vitamin D3:** The 25-OH-Vitamin D3 level is 91.7 nmol/L. While the reference range isn\u2019t provided, this level is significantly low, suggesting a deficiency. This is likely related to her treatment and potential impaired absorption.\n\nTherefore, the abnormal finding is the low 25-OH-Vitamin D3 level.\n\nD"
    },
    {
      "question_id": "patient_07_q6",
      "generated_text": "Let's analyze the provided text snippets about Mrs. Linda Mayer. We need to find a laboratory parameter that was elevated beyond the reference range during her discharge in September 2019.\n\nLooking at the text, we find this information in the final discharge report:\n\n\u201cLab results upon Discharge:\n  **Parameter**                 **Results**   **Reference Range**\n  ----------------------------- ------------- ---------------------\n  Sodium (Na)                   141 mEq/L     134-145 mEq/L\n  Potassium (K)                 3.7 mEq/L     3.4-5.2 mEq/L\n  Calcium (Ca)                  2.37 mEq/L    2.15-2.65 mEq/L\n  Chloride (Cl)                 106 mEq/L     95-112 mEq/L\n  Inorganic Phosphate (PO4)     0.93 mEq/L    0.8-1.5 mEq/L\n  Transferrin Saturation        20 %          16-45 %\n  Magnesium                     0.78 mEq/L    0.75-1.06 mEq/L\n  Creatinine                    1.88 mg/dL    \\<1.2 mg/dL\n  GFR                           36 mL/min     \\<90 mL/min\n  BUN                           60 mg/dL      14-46 mg/dL\n  Uric Acid                     4.6 mg/dL     3.0-6.9 mg/dL\n  Total Bilirubin               0.5 mg/dL     \\<1 mg/dL\n  Albumin                       4.0 g/dL      3.6-5.0 g/dL\u201d\n\nThe only parameter listed that is clearly above the reference range is Total Bilirubin, which reads 0.5 mg/dL.\n\n**A**"
    },
    {
      "question_id": "patient_07_q7",
      "generated_text": "Let's analyze the provided medical records for Mrs. Linda Mayer. We are looking for a bacterial organism that was *not* identified in her lesional skin swabs.\n\nThe records state the following bacterial findings:\n*   Pseudomonas aeruginosa\n*   MRSA\n*   Klebsiella oxytoca\n*   Serratia sp.\n\nEscherichia coli is not listed as one of the identified organisms.\n\n**E**"
    },
    {
      "question_id": "patient_07_q8",
      "generated_text": "Let\u2019s analyze the provided medical records to determine the correct TNM classification.\n\n1. **Diagnosis:** The initial diagnosis is \u201cVacuum-assisted biopsy-confirmed ductal carcinoma in situ (DCIS) of the right breast.\u201d This indicates a localized, non-invasive form of cancer.\n\n2. **Resection Status:** The pathology report states \u201cResection status indicates locally complete excision of both invasive and non-invasive carcinomas; minimal margins as follows\u2026\u201d This means the tumor was completely removed with small margins.  \u201cR0\u201d indicates no regional lymph node involvement at the time of surgery.\n\n3. **TNM Staging:**\n   *   **pT:**  Refers to the primary tumor size and extent. Given the biopsy confirmed DCIS (a localized, non-invasive tumor), the classification is pTis (TIS stands for Tis - Tumor In Situ).\n   *   **pN:** Refers to the regional lymph node involvement. The report indicates \"no evidence of metastatic disease\" implying no lymph node involvement; therefore, it\u2019s pN0.\n   *   **G:** Refers to the grade of the tumor. The report states \u201cGrade 3\u201d, so G3.\n\nConsidering these findings, the correct TNM classification is pTis (DCIS), R0, G3.\n\n**A**"
    },
    {
      "question_id": "patient_07_q9",
      "generated_text": "Let's analyze the provided text regarding the histopathological examination of Mrs. Mayer's skin spindle. The report states: \u201cSkin spindle: Fixed. Skin spindle measuring 9.2 x 6.5 x 5.2 cm with a maximum 4 cm wide perirenal fat tissue and maximum 1 cm wide perihilar fat tissue. Also, a 5 cm long ureter, max 1 cm hilar vessels, and a 2.1 x 1.3 x 0.8 cm adrenal gland at the upper pole of the kidney. In the sections at the renal hilum, there is a maximum 4.3 cm grayish induration. No clear infiltration of vessels by the induration is visible macroscopically.\u201d\n\nThe key finding is that there was no evidence of malignancy. Looking at the options:\n\n*   **A. Multilayered keratinizing squamous epithelium:** This *was* present, as indicated in the report.\n*   **B. Fibrosis and chronic inflammation:** This *was* present.\n*   **C. Atypical epithelial infiltrates:** This *was* present, as indicated as suspicious findings.\n*   **D. Mononuclear-dominated inflammatory infiltrates:** This *was* present.\n*   **E. Proliferation of collagenous connective tissue:** This *was* present, described as \u201cfibrosis\u201d.\n\nSince the question asks what was *not* found, and all of the options are described as present, there seems to be an issue in the data. However, we are asked to choose an answer based on the information provided. Considering the description, the statement most accurately representing what was *not* found is that there was no evidence of malignancy. Given that the options are microscopic findings, this isn't a direct answer. Therefore the best answer is the absence of malignancy. However, as the question demands one of the listed options, let's reassess.\n\nThe question asks specifically about the skin spindle, and within that context, the histological description does not mention evidence of malignancy. The other features listed are all parts of the surrounding tissue, not the skin spindle itself.\n\n**C**"
    },
    {
      "question_id": "patient_07_q10",
      "generated_text": "Let\u2019s analyze the provided patient information to determine which medication was used for pain management in July 2019 but not in January 2021.\n\n*   **July 2019:** The patient was experiencing pain related to the diagnosis of breast carcinoma and was treated with Tramadol/Naloxone (Ultram) for pain management.\n*   **January 2021:** The medication list shows Prednisolone (Prelone) was used. Tramadol/Naloxone was not present.\n\nTherefore, the correct answer is C.\n\nC"
    },
    {
      "question_id": "patient_07_q11",
      "generated_text": "Let\u2019s analyze the patient\u2019s medication history to determine which drug\u2019s dosing frequency was reduced, suggesting clinical improvement.\n\n*   **2019:** The patient was taking Aspirin 100mg once daily, Simvastatin 40mg once daily, and Pantoprazole 40mg once daily.\n*   **2020/2021:** The patient was later treated with Atezolizumab/Bevacizumab, and then transitioned to Vinflunine. During this period, Pantoprazole was reduced to 80mg once daily.\n*   The question specifically asks about the *reduction* in dosing frequency.\n\nTherefore, Pantoprazole's dose was lowered from once daily to every other day.\n\nD"
    },
    {
      "question_id": "patient_07_q12",
      "generated_text": "Let's analyze the provided text about Linda Mayer's surgery. The text describes a left subcutaneous mastectomy with dual-filament markings: green for cranial, yellow for caudal, blue for ventral, and black for dorsal. The text specifically states \"Margin-forming carcinoma infiltrates at the main preparation hilar near the renal vein, with the cranial hilar resection margins I and II being carcinoma-free.\"\n\nThe caudal margin is described as being marked with yellow.\n\nD"
    },
    {
      "question_id": "patient_07_q13",
      "generated_text": "The patient\u2019s medical history states that she was postmenopausal for eight years.\n\nB"
    },
    {
      "question_id": "patient_07_q14",
      "generated_text": "Let's analyze the provided patient information. The text states: \"Allergies: Hay fever\".\n\nTherefore, the correct answer is C.\n\nC"
    },
    {
      "question_id": "patient_07_q15",
      "generated_text": "Let's analyze the provided patient notes. We're looking for the date of the tumor board decision regarding Mrs. Mayer's breast carcinoma.\n\n*   **07.13.19:** This date is mentioned in the first report as the decision regarding the initial diagnosis of DCIS.\n*   **08.30.12:** This date is irrelevant as it pertains to a previous surgery (cholecystectomy).\n*   **09.01.19:** This date is mentioned in the second report as the date of the nephroureterectomy.\n*   **08.27.19:** This date is irrelevant.\n*   **09.12.19:** This date is mentioned in the final report as the date of Mrs. Mayer's discharge.\n\nThe tumor board decision was made on 07.13.19, which indicated a recommendation for further investigations.\n\n**A**"
    },
    {
      "question_id": "patient_07_q16",
      "generated_text": "Let\u2019s analyze the provided text regarding Mrs. Mayer\u2019s surgery. The text states: \u201cRight breast carcinoma: pT3, pN0 (0/11), M1 (ADR), Pn1, L1, V1. Resection margins: Ventral 0.15 cm, Caudal 0.2 cm, Dorsal 0.4 cm\u201d.\n\nTherefore, the correct answer is B.\n\nB"
    },
    {
      "question_id": "patient_07_q17",
      "generated_text": "Let's analyze the provided patient data. The text contains a table of lab results upon discharge. Looking at the table, we find the platelet count listed as \"281 K/uL\".\n\n**B**"
    },
    {
      "question_id": "patient_07_q18",
      "generated_text": "Let's analyze the provided text to find the concentration of prednicarbate cream used by Mrs. Mayer.\n\nThe text states: \"We were able to discharge Mr. Wells in good general condition after unremarkable laboratory checks. During the patient\u2019s hospital stay, we began treatment with a topical application of prednicarbate (Dermatop) 0.25%.\"\n\nTherefore, the concentration of the prednicarbate cream used was 0.25%.\n\nD"
    },
    {
      "question_id": "patient_07_q19",
      "generated_text": "Let's analyze the patient's timeline of imaging procedures based on the provided text snippets:\n\n1.  **Initial Diagnosis & Early Imaging:** The initial diagnosis of DCIS involved a mammogram, followed by a breast MRI.\n2.  **Further Investigation:** Subsequent imaging included a CT scan of the chest and abdomen to rule out metastasis and a sonographically guided biopsy.\n3.  **Final Imaging:** A final MRI was performed.\n\nConsidering this sequence, option B best reflects the chronology.\n\nB"
    },
    {
      "question_id": "patient_08_q0",
      "generated_text": "Let's analyze the provided text regarding Laura Miller's medical history. The text states: \"CT imaging revealed the same results as the previous examination. Known osteoporotic changes were observed in the spine. Specifically, multiple vertebral bodies showed decreased height, most notably at the central region where a measurement of approximately 17 mm suggests significant height loss and potential acute fracture. Additionally, there were endplate impressions in individual vertebrae of the lower thoracic spine.\u201d\n\nThe text explicitly mentions \u201cmultiple vertebrae\u201d exhibiting decreased height, with a particular emphasis on \u201cmost notably at the central region where a measurement of approximately 17 mm suggests significant height loss\u201d. Specifically, it mentions \u201cTh8\u201d and \u201cL1\u201d.\n\nTherefore, the correct answer is:\n\nA"
    },
    {
      "question_id": "patient_08_q1",
      "generated_text": "Let's analyze the provided text snippets about Laura Miller. We're looking for a finding noted in her thoracic spine CT scan.\n\nThe relevant section is: \u201cCT Thorax (Plain) from 01/16/2019: Presence of axillary and mediastinal lymph nodes with borderline enlarged lymph nodes ventral to the tracheal bifurcation (approximately 10 mm).\u201d\n\nThis clearly states the finding is enlarged lymph nodes. Now let's examine the options:\n\n*   A. Kidney Stones - Not mentioned.\n*   B. Liver Cirrhosis - This is her primary diagnosis, but not a finding on a spine CT.\n*   C. Gallbladder Hydrops - Not mentioned.\n*   D. Splenomegaly - Not mentioned.\n*   E. Aortic sclerosis - Not mentioned.\n\nThe enlarged lymph nodes are the noted finding.\n\nD\n\nD"
    },
    {
      "question_id": "patient_08_q2",
      "generated_text": "Let\u2019s analyze the provided text to determine Laura Miller\u2019s analgesia medication in May 2020. The text mentions that she was admitted on 08/21/2020 and received \u201cPantoprazole (Protonix)\u201d for reflux esophagitis. Later, the text reports she was admitted on 03/17/2020 and received \u201cAspirin 100mg 1-0-0\u201d (once daily). Since the question asks about May 2020, we need to look for any mention of analgesics administered during that month. We find no explicit mention of any pain medication besides Aspirin in the provided data. However, the most likely pain relief medication would be Acetaminophen (Paracetamol).\n\nB"
    },
    {
      "question_id": "patient_08_q3",
      "generated_text": "Let\u2019s analyze the provided text. The text states: \u201cThe patient has been diagnosed with esophageal varices, with the findings stating that they are classified as III\u00b0.\u201d The Sarin\u2019s classification system categorizes esophageal varices into grades I-IV based on the severity of the bleeding risk. Grade III indicates a high risk of bleeding. Therefore, the classification is GOV3, not GOV1. However, given the options available, GOV1 is the closest available option.\n\nA"
    },
    {
      "question_id": "patient_08_q4",
      "generated_text": "Let's analyze the provided text. The text mentions \u201cCT Thorax (Plain) from 06/13/2020\u201d and \u201cCT Chest/Abdomen/Pelvis on 06/13/2020\u201d.\n\nB"
    },
    {
      "question_id": "patient_08_q5",
      "generated_text": "Let's analyze the provided text snippets to find the date of the thoracic spine kyphoplasty performed on Laura Miller.\n\nHere's a breakdown of the relevant information:\n\n*   **Snippet 1 (01/16/2019):** Reports a diagnostic ureterorenoscopy and placement of a left DJ stent.\n*   **Snippet 2 (03/18/2019):** States that \u201cOpen left nephroureterectomy with the detection of urothelial carcinoma of the renal pelvis and adrenal metastasis, pT3, pN0, (0/11), M1 (ADR), pn1, L1, V1, high-grade.\u201d\n*   **Snippet 3 (06/08/2020):** Reports \u201cCT-guided liver biopsy on 06/07/2020.\u201d\n*   **Snippet 4 (06/29/2020):** Reports that Mr. Rudolph presented to our outpatient clinic for \u201cthe aforementioned procedure.\u201d It states, \u201cThe procedure was performed on 03/18/2019, without complications.\u201d\n\nTherefore, the thoracic spine kyphoplasty was performed on 03/18/2019.\n\nB"
    },
    {
      "question_id": "patient_08_q6",
      "generated_text": "Let's analyze the provided text. The text states: \"We are reporting on Mr. Peter Rudolph, born on 05/26/1954, who was under our care from 03/17/2019 to 03/18/2019. Laura Miller... CT-guided liver biopsy was performed on 03/17/2019.\u201d Then, further down: \u201cWe are reporting on Laura Miller, born on 04/03/1967, who was under our inpatient care from 08/21/2020 to 08/23/2020. CT-guided liver biopsy on 08/13/2020\u201d Finally, the last report states \u201cWe are reporting on Mr. Peter Rudolph, born on 05/26/1954, who was under our outpatient clinic on 06/29/2020. CT scan of the chest / abdomen/ pelvis on 06/07/2020\u201d. \n\nTherefore, the total spine MRI plain was conducted on 06/13/2020.\n\nC"
    },
    {
      "question_id": "patient_08_q7",
      "generated_text": "Let's analyze the provided reports. We are looking for the date of her last inpatient treatment.\n\n*   Report 1 (07/26/2019) \u2013 Initial presentation with HCC\n*   Report 2 (08/13/2020) \u2013 Admission for complications related to HCC\n*   Report 3 (08/24/2020) \u2013 Start of immunotherapy\n*   Report 4 (09/18/2020) \u2013 Inpatient treatment for symptoms\n*   Report 5 (09/20/2020) \u2013 Inpatient treatment for symptoms\n*   Report 6 (02/22/2022) \u2013 Inpatient treatment for hernia repair\n\nThe most recent inpatient treatment is reported in Report 6, dated 02/22/2022.\n\nD"
    },
    {
      "question_id": "patient_08_q8",
      "generated_text": "Let's analyze the provided text regarding Laura Miller's MR Liver report from 06/06/2020. The report states: \"The largest lesion in the liver measures 4.3 cm\".\n\nTherefore, the correct answer is C.\n\nC"
    },
    {
      "question_id": "patient_08_q9",
      "generated_text": "Let's analyze the provided patient updates to determine the significant change leading to the liver board decision on 08/21/2020.\n\n1. **Initial Diagnosis:** Laura Miller had established liver cirrhosis due to ethyltoxic genesis.\n\n2. **Subsequent Findings:** Later updates revealed the presence of multifocal hepatocellular carcinoma (HCC) lesions, initially in segments 4, 7, and 8.\n\n3. **Progression:** Subsequent reports indicated progression of the HCC, specifically with larger lesions and metastasis to the adrenal gland.\n\n4. **Treatment:** She received chemotherapy (Gemcitabine/Cisplatin) followed by immunotherapy (Nivolumab).\n\n5. **Liver Board Decision:** The liver board decided to initiate a new line of treatment (Vinflunin) due to the HCC progression.\n\nConsidering this progression, the most significant change was the development of multiple HCC lesions and their spread.\n\nB"
    },
    {
      "question_id": "patient_08_q10",
      "generated_text": "Let\u2019s analyze the provided text regarding Laura Miller\u2019s medical history. The text states: \u201cEsophagogastroduodenoscopy on 08/21/2020: Esophagus: Unobstructed intubation of the esophageal orifice under visualization. Mucosa appears inconspicuous, with the Z-line at 37 cm and measuring less than 5 mm. Small mucosal lesions are observed but do not straddle mucosal folds. Stomach: The gastric lumen is completely distended under air insufflation. There are streaky changes in the antrum, while the fundus and cardia appear regular on inversion. The pylorus is inconspicuous and passable.\u201d\n\nThe report also mentions \u201cresidual varices in the esophagus.\u201d This indicates the presence of esophageal varices. Alarm signs were noted, specifically \u201cvarices with risk signs\u201d (red spots).\n\nTherefore, the correct answer is E.\n\nE"
    },
    {
      "question_id": "patient_08_q11",
      "generated_text": "Let's analyze the provided patient notes. We are looking for a CT scan of the chest/abdomen/pelvis with contrast agent.\n\nLooking through the notes, the relevant entry is from 06/07/2020, where a CT scan was performed.\n\nD"
    },
    {
      "question_id": "patient_08_q12",
      "generated_text": "Let's analyze the provided patient notes. The text indicates that on 08/21/2020, Laura Miller underwent a \u201cCT-guided liver biopsy\u201d. This aligns with option A, \u201cMRI of the liver\u201d being incorrect, B, \u201cUltrasound of the upper abdomen\u201d being incorrect, C, \u201cEsophagogastroduodenoscopy with banding therapy\u201d being incorrect, D, \u201cCT Chest/Abdomen/Pelvis with contrast\u201d being incorrect, and E, \u201cKyphoplasty of thoracic vertebra 8\u201d being incorrect.\n\nA"
    },
    {
      "question_id": "patient_08_q13",
      "generated_text": "Let's analyze the provided text snippets. We're looking for the date of the \"MR Liver plain + contrast agent examination.\"\n\nScanning through the texts, we find the relevant information in the following excerpt: \u201cWe are reporting on Mr. Peter Rudolph, born on 05/26/1954, who was under our care from 06/08/2020 to 06/29/2020.\n\n**Diagnoses**:\n\n-   MR Liver: Disseminated HCC foci in all segments, the largest foci is located in segments 5 / 7 / 8\u2026\u201d\n\nThis clearly indicates that the MR Liver examination was performed on 06/08/2020.\n\n**C**"
    },
    {
      "question_id": "patient_08_q14",
      "generated_text": "Let's analyze the provided patient notes. The text mentions \u201cUltrasound of the liver\u201d performed on 05/27/2020, which is when the diagnosis of liver cirrhosis was first established.\n\n**A. 05/29/2020** \u2013 This date is later than the initial ultrasound.\n**B. 06/30/2020** \u2013 This date is too late.\n**C. 06/04/2020** \u2013 This date is too late.\n**D. 06/06/2020** \u2013 This date is too late.\n**E. 05/27/2020** \u2013 This date is the correct date when the ultrasound showing liver cirrhosis was performed.\n\nD"
    },
    {
      "question_id": "patient_08_q15",
      "generated_text": "Let's analyze the provided text snippets to determine Mrs. Miller\u2019s condition upon admission to the hospital on 09/18/2020.\n\nThe text describes several conditions:\n\n*   **Liver cirrhosis:** This is her primary diagnosis.\n*   **Child-Pugh B cirrhosis:** This indicates a moderate stage of the liver disease.\n*   **Ethyltoxic genesis:** This is the cause of the cirrhosis, linked to alcohol consumption.\n*   **Transfusion-dependent anemia:** She required two blood transfusions.\n*   **Residual esophageal varices:** Following banding therapy, she had varices remaining.\n*   **Arterial hypertension:** She had high blood pressure.\n\nAll of these conditions were present upon admission.\n\nE"
    },
    {
      "question_id": "patient_08_q16",
      "generated_text": "Let's analyze the provided text about patient Laura Miller. The CT scan report from 06/18/2020 states: \"Known exophytic liver lesions in segments 3/4 and 7/8, with no evidence of suspicious thoracoabdominal tumors or lymph nodes.\" It also mentions \u201csignificant changes in the liver\u201d and \u201cmultiple, some large liver metastases.\u201d The report explicitly notes \u201cbilateral minor pleural effusions.\u201d\n\nTherefore, the correct answer is E.\n\nE"
    },
    {
      "question_id": "patient_08_q17",
      "generated_text": "Let's analyze the provided text to determine Mrs. Miller's nutritional status as of 06/08/2020. The text states:\n\n*   \u201cAlbumin at 2.6\u201d - This indicates a low level of albumin in the blood, which is a marker of malnutrition.\n*   \u201cBMI falsified by ascites\u201d - Ascites (fluid buildup in the abdomen) distorts the BMI measurement, suggesting an inaccurate assessment.\n*   \u201cPatient reports that she always a \u2018bad eater\u2019\u201d.\n*   \u201cPatient appears desperate and seems very burdened by diagnosis\u201d.\n\nThese factors collectively point towards malnutrition, specifically protein malnutrition. The BMI being falsified due to ascites also contributes to this conclusion.\n\nC"
    },
    {
      "question_id": "patient_08_q18",
      "generated_text": "Let's analyze the provided text snippets to determine which medication was not listed as part of Mrs. Miller\u2019s treatment.\n\n*   **Snippet 1:** Mentions Aspirin (blood pressure medication)\n*   **Snippet 2:** Mentions Bisoprolol (blood pressure medication)\n*   **Snippet 3:** Mentions Pantoprazole (a medication for reflux esophagitis)\n*   **Snippet 4:** Mentions Prednisolone (for rheumatic symptoms)\n*   **Snippet 5:** Mentions antibiotics (Ceftriaxone and Azithromycin).\n\nNone of the snippets explicitly state the use of osteoporosis medication, anticoagulation medication, or pain relief medication.\n\nTherefore, the correct answer is:\n\nC"
    },
    {
      "question_id": "patient_08_q19",
      "generated_text": "Let's break down the chronology of Mrs. Miller's imaging studies based on the provided medical reports:\n\n1.  **Initial Concerns:** The initial presentation involved persistent right upper abdominal pain, leading to a CT scan of the chest and abdomen.\n2.  **Liver Investigation:** Following the CT scan, an abdominal ultrasound was performed to further investigate the liver findings.\n3.  **Ureteroscopy:** An esophagogastroduodenoscopy was performed to assess the ureter and renal pelvis.\n4.  **Biopsy & Further Imaging:** A CT-guided liver biopsy was performed.\n5.  **Spinal Imaging:**  A spinal X-ray was performed to assess the vertebrae.\n6.  **Detailed Spine Imaging:** Subsequently, a more detailed MRI of the spine was obtained.\n7.  **Comprehensive Liver Imaging:** A full MRI of the liver was performed.\n8. **Final CT scan of the whole body:** Final CT scan completed to assess the patient.\n\nConsidering this sequence, option **B** most accurately represents the chronological order of the radiology examinations.\n\nB"
    },
    {
      "question_id": "patient_09_q0",
      "generated_text": "Let's analyze the provided text. We are looking for the size of a specific lesion (an \"echo-depleted mass\") in Mr. Wells' liver Segment IV as reported on 07/26/2019. The text states: \u201cLarge, partly exophytic, partly centrally hemorrhagic HCC lesions in S3/4 and S7/8\u2026 Previously, a 4.2 x 2.5 cm lesion was observed in segment 4.\u201d\n\nTherefore, the size of the mass in Segment IV was 4.2 x 2.5 cm. However, a question asks for the current size. I need to confirm this information with the text.\n\nLooking at the previous text, the correct answer is C.\n\nC"
    },
    {
      "question_id": "patient_09_q1",
      "generated_text": "Let\u2019s analyze the provided patient information and the question. The question asks about the characteristics noted on Mr. Wells\u2019 MRI of the liver taken on 07/26/2019. The text states: \"MRI imaging revealed large, partly exophytic, partly centrally hemorrhagic HCC lesions in segments S3/4 and S7/8, complete infiltration of the left lateral lobe with smaller satellites, and macrovascular invasion of the left portal vein.\u201d\n\nNow, let\u2019s evaluate the answer options:\n\n*   **A. T1 hyperintensity and venous phase enhancement:** This doesn\u2019t align with the description of \u201chemorrhagic\u201d lesions.\n*   **B. T2 hyperintensity, marked diffusion restriction, arterial phase enhancement, and venous phase washout:** This aligns perfectly with the description of the lesions \u2013 \u201cmarked diffusion restriction\u201d and \u201cvenous phase washout\u201d are key characteristics mentioned.\n*   **C. T2 hyperintensity, marked diffusion restriction, no visible arterial phase enhancement, and venous phase washout:**  The description states arterial phase enhancement.\n*   **D. Solid appearance with no significant enhancement:** The lesions were described as \u201cexophytic\u201d and \u201chemorrhagic,\u201d suggesting some degree of enhancement.\n*   **E. T1 hypointensity and no washout:**  This contradicts the \u201chemorrhagic\u201d aspect of the lesions.\n\nTherefore, the best answer is B.\n\nB"
    },
    {
      "question_id": "patient_09_q2",
      "generated_text": "Let's analyze the provided text snippets to determine the answer.\n\nThe text mentions a colonoscopy performed on 07/28/2019. The report states that \u201cDuring the colonoscopy, a 4mm polyp was observed in the sigmoid colon and was removed with a cold snare.\u201d\n\nTherefore, the correct answer is:\n\nB"
    },
    {
      "question_id": "patient_09_q3",
      "generated_text": "Let's analyze the provided text to determine the liver fibrosis stage. The text states: \"Liver fibrosis: Elevated alcohol consumption (3-4 beers/day).\u201d, indicating a history of alcohol consumption, and the progression of the disease shows the elevated C2 consumption - which points toward a more advanced form of liver fibrosis.\n\nGiven the information, the best answer is Stage 3.\n\nD"
    },
    {
      "question_id": "patient_09_q4",
      "generated_text": "Let\u2019s analyze the provided patient notes to determine which complication Mr. Wells *did not* experience after receiving Atezolizumab/Bevacizumab.\n\n*   **High blood pressure:** The notes mention elevated blood pressure, but no significant hypertension.\n*   **Elevated transaminases:** The patient experienced a significant increase in transaminase levels, prompting a pause in the treatment.\n*   **Worsening pulmonary status:** The patient experienced worsening respiratory symptoms, requiring oxygen supplementation.\n*   **Severe pneumonic sepsis:** The patient developed pneumonic sepsis during a hospitalization.\n*   **Oral burning:** The patient reported oral burning as a side effect of the medication.\n\nBased on this, the complication Mr. Wells did not experience is the absence of oral burning.\n\n**E**"
    },
    {
      "question_id": "patient_09_q5",
      "generated_text": "Let's analyze the provided text snippets to determine the date of Mr. Wells' CAP diagnosis.\n\n*   **Snippet 1 (02/04/2019):** Mentions his birthdate and initial diagnoses, including a nephroureterectomy for urothelial carcinoma.\n*   **Snippet 2 (03/17/2019):** Reports the diagnosis of metastatic urothelial carcinoma.\n*   **Snippet 3 (08/13/2020):** Details the diagnosis of Community-Acquired Pneumonia (CAP).\n\nTherefore, the correct answer is B.\n\nB"
    },
    {
      "question_id": "patient_09_q6",
      "generated_text": "Let's analyze the provided text regarding Mr. Wells' medical history. The text states that he presented with symptoms of pneumonic sepsis, including fever, productive cough with yellow-green sputum, and pleuritic chest pain. Furthermore, the laboratory results identified *Streptococcus pneumoniae* as the causative pathogen.\n\nB"
    },
    {
      "question_id": "patient_09_q7",
      "generated_text": "Let's analyze the provided text snippets regarding Mr. Wells' medical history. Specifically, we need to focus on the MRI findings from 11/20/2020. The text states: \u201cMRI Liver (plain + contrast agent) on 11/20/2020 revealed stable findings in the liver. The previously identified HCC lesions in segments IV, VII/VIII, including their size and characteristics, remained largely unchanged.\u201d\n\nTherefore, the correct answer is B.\n\nB"
    },
    {
      "question_id": "patient_09_q8",
      "generated_text": "Let's analyze the provided text snippets to determine Mr. Wells' COPD severity level as of 11/20/2020.\n\nThe text mentions: \"COPD, current severity level Gold III.\"\n\nTherefore, the correct answer is:\n\nC"
    },
    {
      "question_id": "patient_09_q9",
      "generated_text": "Let's analyze the provided patient notes to determine the reason for Mr. Wells' home oxygen therapy. The notes repeatedly mention his COPD (Chronic Obstructive Pulmonary Disease) and respiratory partial insufficiency. These conditions necessitate supplemental oxygen to support his breathing.\n\nA. Asthma \u2013 While asthma can cause breathing difficulties, the notes don't describe the specific symptoms associated with asthma.\nB. Pulmonary Embolism \u2013 The notes do not indicate a recent pulmonary embolism.\nC. Lung Cancer \u2013 While he has lung cancer, the focus is on his respiratory distress, not the cancer itself.\nD. Pulmonary Emphysema \u2013 This is a key component of his COPD diagnosis and explains his reduced lung function.\nE. Tuberculosis \u2013 The notes don\u2019t suggest tuberculosis as the cause of his respiratory issues.\n\n**D**"
    },
    {
      "question_id": "patient_09_q10",
      "generated_text": "Let's analyze the provided patient notes to determine Mr. Wells' GFR upon discharge.\n\nThe patient\u2019s notes repeatedly mention lab results. Specifically, a lab result from 08/26/2021 states: \u201cGFR: 36 mL/min\u201d. This is the GFR value indicated on his discharge.\n\n**D**"
    },
    {
      "question_id": "patient_09_q11",
      "generated_text": "Let's analyze the provided text snippets to find the total bilirubin level reported upon Mr. Wells' discharge.\n\nHere\u2019s a breakdown of the relevant information:\n\n*   **Snippet 3:** \u201c\u2026Current Medication: **Medication upon Discharge:**\n    **Parameter**                 **Results**   **Reference Range**\n    **Total Bilirubin**           **0.5 mg/dL**     \\<1 mg/dL\u201d\n\nTherefore, the total bilirubin level in Mr. Wells\u2019 lab results upon discharge was 0.5 mg/dL.\n\n**A**"
    },
    {
      "question_id": "patient_09_q12",
      "generated_text": "Let's analyze the provided medical reports to determine the first diagnostic procedure performed on Mr. Wells after his admission on 07/26/2019.\n\nThe reports detail his initial presentation with right upper abdominal pain and suspected liver lesions. The initial investigation was a CT scan of the thorax. Subsequently, a CT scan of the abdomen and pelvis was conducted to further assess the liver lesions. Then, a liver biopsy was performed. The gastroscopy and colonoscopy were performed later.\n\nTherefore, the first diagnostic procedure was a CT scan of the chest, abdomen and pelvis.\n\nC"
    },
    {
      "question_id": "patient_09_q13",
      "generated_text": "Let's analyze the provided text to determine when Atezolizumab/Bevacizumab was first administered to Mr. Wells.\n\nThe text states: \"\u2026Atezolizumab/Bevacizumab commenced on 08/24/2019.\"\n\nTherefore, the correct answer is B.\n\nB"
    },
    {
      "question_id": "patient_09_q14",
      "generated_text": "Let's analyze the provided patient notes to determine when Mr. Wells was first admitted for SIRT simulation.\n\n*   **08/13/2019:** The notes mention a discussion about SIRT simulation but don\u2019t specify an admission date.\n*   **08/13/2020:** The notes state that he was admitted on this date for the SIRT simulation.\n*   **07/26/2019:** This date is related to the initial diagnosis of HCC.\n*   **04/02/2021:** This date is connected to another admission for follow-up.\n*   **10/24/2020:** This date is related to the diagnosis of a new liver metastasis and subsequent treatment plan.\n\nThe clearest indication is that he was admitted for the SIRT simulation on 08/13/2020.\n\nB"
    },
    {
      "question_id": "patient_09_q15",
      "generated_text": "Let\u2019s analyze the provided text to determine the sequence of imaging tests performed on 11/20/2020.\n\nThe text states: \u201cCT Thorax (Plain) from 01/20/2020: Presence of axillary and mediastinal lymph nodes...\u201d. This indicates a CT scan was performed prior to 11/20/2020.\n\nThen, the text states: \u201cCT Chest/Abdomen/Pelvis with contrast agent on 11/20/2020: \u2026\u201d. This confirms that a CT scan was performed on 11/20/2020.\n\nFollowing the CT scan, the text mentions: \u201cCT-guided liver biopsy on 11/04/2020.\u201d Therefore, the MRI was performed *after* the CT scan.\n\nConsidering this, the correct sequence is CT followed by MRI.\n\nD"
    },
    {
      "question_id": "patient_09_q16",
      "generated_text": "Let's analyze the provided text snippets to determine when the liver tumor board decision for systemic therapy was made.\n\nThe text describes a series of events:\n*   Initial diagnosis of HCC in July 2019 (07/20/2019).\n*   Decision for adjuvant chemotherapy in July 2019 (07/19).\n*   Later, a decision to initiate systemic therapy with Atezolizumab/Bevacizumab was made on 08/18/2019.\n\nTherefore, the correct answer is B.\n\nB"
    },
    {
      "question_id": "patient_09_q17",
      "generated_text": "Let's analyze the provided medical history to determine the correct chronological order of the initial diagnostic procedures.\n\n1.  **07/26/2019 Admission:** Mr. Wells is admitted with suspected liver metastases.\n\n2.  **Initial Imaging:** The first step would likely be to get a baseline assessment of the liver using imaging.  An MRI is a more detailed imaging technique than a CT scan and is typically performed first when evaluating complex liver lesions.\n\n3.  **Liver Biopsy:** To confirm the diagnosis and characterize the lesions, a liver biopsy guided by ultrasound is performed. This is crucial for determining the type and grade of the cancer.\n\n4.  **Further Imaging:** After the biopsy, a CT scan of the chest, abdomen, and pelvis would be conducted to assess for distant metastases. Gastroscopy is performed for screening purposes, but the liver biopsy is the priority.\n\nTherefore, the correct sequence is MRI Liver, Ultrasound-guided liver puncture, and then CT scan.\n\nD"
    },
    {
      "question_id": "patient_09_q18",
      "generated_text": "Let's analyze the provided medical records to determine the reason for the pause in Atezolizumab/Bevacizumab therapy for Mr. Wells.\n\nThe records detail a history of HCC, subsequent chemotherapy, immunotherapy, and finally, a diagnosis of an incisional hernia repair. Crucially, there\u2019s a mention of \u201ctransaminase elevation\u201d following the immunotherapy, leading to a temporary pause in treatment. The subsequent note indicates a possible drug-induced hepatitis. While other factors are mentioned (pneumonia, hernia repair), the primary issue directly linked to the therapy modification was the abnormal liver function tests.\n\nTherefore, the most accurate answer is:\n\nD"
    },
    {
      "question_id": "patient_09_q19",
      "generated_text": "Let\u2019s break down the chronological order of the imaging examinations based on the provided text:\n\n1.  **Initial Assessment:** CT Thorax (Plain) - Established the presence of mediastinal and pulmonary lymphadenopathy.\n2.  **Liver Assessment:** MRI Liver \u2013 Detailed evaluation of the liver lesions and their characteristics.\n3.  **Further Liver Investigation:** CT Chest/Abdomen/Pelvis \u2013 Confirmed the liver lesions and ruled out other primary malignancies.\n4.  **Diagnostic Biopsy:** DSA Coeliac-Mesenteric \u2013 Used to access the liver and obtain biopsies.\n5.  **Functional Assessment:** Perfusion Scintigraphy of the Liver and Lungs with SPECT/CT \u2013 Evaluated liver blood flow and function.\n6.  **More detailed liver MRI:** MRI Liver \u2013 performed a second MRI to see the response to the chemotherapy.\n7.  **Gastrointestinal Evaluation:** Gastroscopy and Colonoscopy - Used to examine the esophagus, stomach, and colon for signs of disease or complications.\n\nConsidering this sequence, the correct answer is:\n\nC"
    },
    {
      "question_id": "patient_10_q0",
      "generated_text": "Let's analyze the provided text snippets. We need to find the year Mr. Rudolph had his atrial fibrillation ablation.\n\nSnippet 1 (01/16/2019): Mentions he had an atrial fibrillation ablation in 2013.\nSnippet 2 (08/26/2021): Restates the 2013 ablation.\n\nTherefore, the correct answer is 2013.\n\nC"
    },
    {
      "question_id": "patient_10_q1",
      "generated_text": "Let\u2019s analyze the provided text to determine the procedure performed on Mr. Rudolph in 2010.\n\nThe text states: \u201c2010: pTCA stenting for acute myocardial infarction/CHD\u201d. This clearly describes the procedure performed at that time.\n\nB"
    },
    {
      "question_id": "patient_10_q2",
      "generated_text": "Let's analyze the provided text snippets. The text describes Mr. Rudolph's medical history and treatments. The diagnostic ureterorenoscopy occurred on 01/16/2019.\n\nA"
    },
    {
      "question_id": "patient_10_q3",
      "generated_text": "Let's analyze the provided text snippets to determine the number of biopsies taken during Mr. Rudolph's ureterorenoscopy.\n\nThe text mentions:\n*   \u201cEight biopsies were successfully obtained from the ureter\u2026\u201d\n\nTherefore, the correct answer is C.\n\nC"
    },
    {
      "question_id": "patient_10_q4",
      "generated_text": "Let\u2019s analyze the provided text to determine which procedure was *not* performed on Mr. Rudolph on 01/16/2019.\n\nThe text details the events of that day: \u201cDiagnostic ureterorenoscopy on the left with biopsy and left DJ stent placement on 01/16/2019.\u201d This clearly states that a ureterorenoscopy, biopsy, and stent placement occurred.\n\nLet\u2019s examine each option:\n\n*   **A. Diagnostic ureterorenoscopy on the left:** This *was* performed.\n*   **B. Biopsy of the left ureter:** This *was* performed.\n*   **C. Retrograde urography on the left:** This *was* performed.\n*   **D. DJ catheter placement on the left:** This *was* performed.\n*   **E. Laparoscopic cholecystectomy:** This procedure occurred in 2012, *not* on 01/16/2019.\n\nTherefore, the correct answer is E.\n\nE"
    },
    {
      "question_id": "patient_10_q5",
      "generated_text": "Let\u2019s analyze the provided text. The text states: \u201cDuring the procedure, we administered antibacterial prophylaxis with Ampicillin/Sulbactam 3g.\u201d\n\nTherefore, the correct answer is C.\n\nC"
    },
    {
      "question_id": "patient_10_q6",
      "generated_text": "Let's analyze the provided text snippets to find the date of the cytological report.\n\nSnippet 4 mentions \"Diagnostic ureterorenoscopy on the left with biopsy and left DJ stent placement on 01/16/2019.\" This clearly indicates that the cytological report was performed on January 16, 2019.\n\n**B**"
    },
    {
      "question_id": "patient_10_q7",
      "generated_text": "Let\u2019s analyze the provided text snippets to determine the key pathological finding in Mr. Rudolph\u2019s internal cytological report. The report describes the initial diagnosis as \u201curothelial carcinoma\u201d and details findings such as \u201cnuclear changes,\u201d \u201chyperchromasia,\u201d and \u201cperipheral placement within the cytoplasm.\u201d These features are consistent with malignancy. The report also mentions \u201cpapillary arrangements\u201d which are indicative of malignancy. The other options \u2013 benign proliferation, inflammation, necrosis, and fibrosis \u2013 are not supported by the report\u2019s description.\n\nB"
    },
    {
      "question_id": "patient_10_q8",
      "generated_text": "Let's analyze the provided text snippets to find the answer.\n\nThe relevant information is from the report dated 03/04/2022: \u201cMacroscopy: Skin spindle: Fixed. Skin spindle measuring 9 x 0.5 x 1.5 cm with a centrally located, slightly raised, and indurated scar. Hernia sac I: Fixed. Cap-shaped serosal lamella measuring 8 x 7.5 x 2 cm with a bulging cord-like fibrosis. The serosa is smooth and shiny. Hernia sac II: Fixed. A 15 x 3 x 0.5 cm large, reddish-livid serosal specimen with focal indurations, petechial hemorrhages, and adhesion strands. Multiple cross-sections embedded.\u201d\n\nAdditionally, there is a reference to the size of the mass within the tumor, described as \u201cmaximum 4.3 cm\u201d.\n\nTherefore, the size of the left renal pelvis mass was 4.3 cm.\n\nC"
    },
    {
      "question_id": "patient_10_q9",
      "generated_text": "Okay, let's analyze the provided text to determine the growth of the liver metastasis in Mr. Rudolph.\n\n1.  **Initial Measurement (03/03/2021):** The text states, \u201cA large, partly exophytic, partly centrally hemorrhagic HCC lesions in S3/4 and S7/8, complete infiltration of the left lateral lobe with smaller satellites, macrovascular invasion of the left portal vein.\u201d and \"the largest lesion in segment 5/7/8 was measured at 4.2 cm.\u201d\n\n2.  **Later Measurement (06/07/2021):** The text indicates, \u201cSignificant progression of numerous, some large liver metastases in both liver lobes. For example, a formerly 4.2 x 2.5 cm measuring metastasis has now increased to 5.8 x 3.6 cm.\u201d\n\n3.  **Calculate the Difference:** 5.8 cm (new measurement) - 4.2 cm (initial measurement) = 1.6 cm.\n\nTherefore, the liver metastasis grew by 1.6 cm.\n\nD"
    },
    {
      "question_id": "patient_10_q10",
      "generated_text": "Let's analyze the provided text snippets to determine Mr. Rudolph's medication history.\n\n*   **Snippet 1 (01/17/2019):** Mentions Aspirin, Bisoprolol, and Pantoprazole.\n*   **Snippet 2 (08/26/2020):** Includes Prednisolone.\n*   **Snippet 3 (06/29/2021):** Lists Aspirin, Bisoprolol, and Pantoprazole.\n\nMetformin is not mentioned in any of these reports.\n\n**E**"
    },
    {
      "question_id": "patient_10_q11",
      "generated_text": "Let's analyze the patient's medical history to determine which therapy hasn't been administered.\n\n*   **Gemcitabine/Cisplatin:** He received four cycles of this chemotherapy.\n*   **Nivolumab:** He received 10 cycles of immunotherapy with Nivolumab.\n*   **Immunotherapy:** He received a total of 10 cycles of immunotherapy (including Nivolumab).\n*   **Enfortumab Vedotin:** There is no mention of Enfortumab Vedotin being considered or administered in the provided updates.\n*   **Chemotherapy with Vinflunin:** He received a brief course of Vinflunin as a third-line treatment.\n\nTherefore, the therapy that has not been administered is Enfortumab Vedotin.\n\nD"
    },
    {
      "question_id": "patient_10_q12",
      "generated_text": "Let\u2019s analyze the provided text regarding Mr. Rudolph\u2019s examination. The text states: \u201cThe evaluation is performed to assess a potential left subclavian stenosis with blood pressure side differences.\u201d This clearly indicates that the significant finding was the observation of differences in blood pressure between his right and left arms, suggesting a potential subclavian stenosis.\n\nA\nB\nC\nD\nE\n\nA"
    },
    {
      "question_id": "patient_10_q13",
      "generated_text": "Let\u2019s analyze Mr. Rudolph\u2019s medical history as presented in the provided text snippets.\n\n*   **A. Atrial fibrillation with ablation:** This is explicitly mentioned in multiple reports.\n*   **B. pTCA stenting for acute myocardial infarction/CHD:** This is also clearly documented.\n*   **C. Laparoscopic cholecystectomy:** This is listed as a past procedure.\n*   **D. Left psoas abscess:** This is a recorded event in his history.\n*   **E. Prostatectomy:** There is no mention of a prostatectomy in any of the provided information.\n\nTherefore, the correct answer is E.\n\nE"
    },
    {
      "question_id": "patient_10_q14",
      "generated_text": "Let\u2019s analyze the provided patient notes to determine the medications Mr. Rudolph was prescribed during his last admission (02/22/2022).\n\nThe notes detail his admission for an umbilical hernia repair following prior nephroureterectomy for renal cell carcinoma. The final note explicitly lists his current medications as Aspirin, Bisoprolol, and Pantoprazole.\n\nTherefore, the correct answer is:\n\nA"
    },
    {
      "question_id": "patient_10_q15",
      "generated_text": "Let's analyze the provided patient notes. The patient's history includes a nephroureterectomy in 2019 and a subsequent presentation in February 2022 with an incisional hernia. The note explicitly states \u201coperative procedure: Alloplastic Incisional Hernia Repair\u201d on 02/23/2022.\n\nB"
    },
    {
      "question_id": "patient_10_q16",
      "generated_text": "Let's analyze the patient's medical history. Mr. Rudolph was initially diagnosed with renal cell carcinoma and subsequently received four cycles of adjuvant chemotherapy with Gemcitabine/Cisplatin.\n\nD. Gemcitabine and Cisplatin\n\nD"
    },
    {
      "question_id": "patient_10_q17",
      "generated_text": "Let's analyze the provided text to determine the immunotherapy administered to Mr. Rudolph from May to September 2020.\n\nThe text states: \u201c- 05/20 - 09/20: 10 cycles of immunotherapy with Nivolumab 240 mg q14d.\u201d\n\nTherefore, the immunotherapy administered was Nivolumab.\n\nD"
    },
    {
      "question_id": "patient_10_q18",
      "generated_text": "Okay, let's analyze Mr. Rudolph's medication history to determine how it changed between 06/29/2021 and 02/22/2022.\n\n*   **06/29/2021:** The medication list includes Aspirin, Bisoprolol, Pantoprazole, and Prednisolone.\n*   **02/22/2022:** The medication list includes Aspirin and Pantoprazole, with Prednisolone being discontinued.\n\nTherefore, Pantoprazole was removed from the medication plan.\n\n**E**"
    },
    {
      "question_id": "patient_10_q19",
      "generated_text": "Okay, let's break down the chronological order of Mr. Rudolph\u2019s radiology exams based on the provided text:\n\n1.  **Initial Diagnosis & Imaging:** The initial concern was a potential hernia related to his past nephrectomy. This led to a Chest CT to rule out metastasis.\n2.  **Hernia Assessment:** Following the Chest CT, an Abdominal CT was performed to assess the hernia.\n3.  **Biopsy:** A CT-guided liver biopsy was performed to investigate the new liver metastases.\n4. **Further Imaging:** CT was performed for the liver again.\n\nConsidering this sequence, the correct order is Chest CT, then Abdominal CT, then CT-guided liver biopsy, and then the repeat CT.\n\n**C**"
    }
  ]
}